• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Avenue Therapeutics Inc (NQ: ATXI )

    2.250 -0.140 (-5.86%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Sep 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 37,493
    Open 2.500
    Bid (Size) 2.300 (2)
    Ask (Size) 2.940 (1)
    Prev. Close 2.390
    Today's Range 2.210 - 2.590
    52wk Range 2.210 - 54.15
    Shares Outstanding 8,182,985
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    ATXI Stock Earnings: Avenue Therapeutics Misses EPS for Q2 2024
    ATXI stock results show that Avenue Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -81.25%
    -81.25%
    1 Month
    -19.06%
    -19.06%
    3 Month
    -37.15%
    -37.15%
    6 Month
    -80.13%
    -80.13%
    1 Year
    -94.66%
    -94.66%

    More News

    Read More
    ATXI Stock Earnings: Avenue Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Avenue Therapeutics (ATXI) Stock Is Falling Sharply
    Via Benzinga
    Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Crude Oil Moves Lower; B. Riley Financial Shares Jump
    Via Benzinga
    Exposures Fossil Fuels
    Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Avenue Therapeutics (ATXI) Shares Are Getting Hammered
    Via Benzinga
    Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    ATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Sidoti Events, LLC's Virtual January Micro-Cap Conference
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Avenue Therapeutics Shares Are Getting Hammered
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.